Skip to main content
. 2021 Mar 4;12(7):1014–1022. doi: 10.1111/1759-7714.13814

Figure 4.

Figure 4

Progression‐free survival (PFS) with the chemotherapy regimens used. (Inline graphic) Pemetrexed/Cisplatin, (Inline graphic) Pemetrexed/Carboplatin, (Inline graphic) Gemcitabine/Carboplatin, (Inline graphic) Gemcitabine, (Inline graphic) Gemcitabine/Cisplatin.